Answers are grounded in this paper and cite their sources.
Investigation reveals distinct prognostic value of dual-tracer PET in advanced prostate cancer, suggesting improvement in treatment strategies.
[¹⁸F]FDG PET and [⁶⁸Ga]Ga-PSMA-11 PET provide distinct but complementary prognostic value in advanced hormone-sensitive prostate cancer. Dual-tracer PET imaging enhances prognostic accuracy and provides comprehensive guidance for individualized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: